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Summery of the thesis 
 
1. In this study, we report the fertility treatment approaches in the different prognostic 
groups of patients. The initial steps and the vaginal radical trachelectomy (VRT), as 
the first method is reported. VRT is a worldwide accepted, oncologically safe 
procedure in retaining the fertility of a special group of cervical cancer patients. 
 
2. We introduce the abdominal radical trachelectomy (ART) and our initial experience 
with 30 operated patients. The radicality of the procedure can be identical to that of a 
traditional type III Wertheim hysterectomy. Technically it’s easily adopted by 
surgeons having experience in radical hysterectomy. Obstetrical outcomes are similar 
to those of the historical vaginal radical trachelectomy cohorts. 
 
 
3. Tumor size is an important criterion for fertility preservation surgery in most centers. 
Oncology outcomes are reported acceptable if the tumor does not exceed 2 cm in 
diameter. VRT and ART are generally considered  oncologically safe under the limit 
of 2 cm tumor size. Recurrences in tumors larger than 2 cm (20·8%-28%) shows that 
VRT is a risky procedure for tumors with this feature. Several studies have shown that 
<1% of patients with early cervical cancer with favorable pathologic characteristics 
have parametrial involvement. There are only a few case reports about less radical 
procedures, such as conisation or simple trachelectomy with or without 
lymphadenectomy in cervical cancers < 2 cm of tumor diameter. 
 
4. Over 2 cm of tumor diameter a few studies with different surgical radicality showed 
their results after neoadjuvant chemotherapy. The drawback of all studies in literatures 
is the small sample size and the relatively short follow-up. Neoadjuvant chemotherapy 
in fertility sparing surgery is an experimental concept, which requires verification in 
the future, especially concerning oncological findings.  
 
5. Our goal was to find a surgical method to be used in patients with bulky tumors with  
an acceptable oncological outcome. Höckel et al 82 demonstrated that the most 
probable cause of the cervical cancer recurrence was incomplete removal of 
ligamentous mesometrium adjacent to the mesorectum. We presumed that survival of 
	   5	  
surgically treated patients with cervical cancer might be improved by stringent 
complete removal of the parametria. Between November 1993 and November 2005, 
radical hysterectomy (RH) was performed in 563 consecutive patients with stage IB 
cervical cancer at St. Stephen Hospital. According to our treatment protocol, 492 
(87.4%) of the 563 patients did not receive any adjuvant treatment. Five-year overall 
survival of 492 patients with stage IB cervical cancer treated with radical 
hysterectomy without adjuvant therapy was 94.0%. 
 
6. Our surgical technique during the ART procedure, with regards to the extent of 
clearance of the tumor cell containing pelvic connective tissue, is identical to RH. Our 
hypothesis was that oncology safety of patients diagnosed with tumours >2cm in 
diameter and treated by ART would be similar to cases managed by RH. Between 
January 1999 and October 2006, a total of 36 patients with cervical carcinoma FIGO 
stage IB1-IB2 measuring greater than 2cm in diameter were explored with the intent 
of a fertility sparing ART and pelvic lymphadenectomy. 22 patients were eligible for 
ART procedure based on our exclusion criteria. Mean 5-year overall survival of ART 
patients over 2 cm of tumor was 95%. Out of the 22 patients, eight wished to fall 
pregnant. Four pregnancies were recorded in three patients. One pregnancy resulted in 
a first trimester miscarriage. Three pregnancies led to delivery of a healthy neonate, 
one at 28 weeks gestation and two at term. Although still preliminary, our results are 
encouraging and indicate that even tumours > 4cm may be successfully treated with 
ART. 
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Objectives and findings of the present study 
 
 
Objectives of introducing ART (subject of the present study): 
 
 
1. Fertility preservation in FIGO IA2 and IB cervical cancer patients – Initial steps and 
VRT 
2. The development of a surgical technique, that can be adopted by gynecologic 
oncologists without a special training in vaginal radical approaches. ART 
3. Study the oncological outcome, pregnancy outcome and quality of life consequences  
4. Study the fertility preserving treatment options in cervical cancer patients under 2 cm 
of tumor diameter 
5. Study surgical treatment of cervical cancer patients in FIGO I/B stadium without 
adjuvant therapy 
6. Study the feasibility of the fertility preserving operation in terms of oncological 
outcome in cases where the tumor diameter is above 2 cm. 
 
 
 
Findings of the present study: 
 
1. VRT is a safe option in fertility preservation, but it needs a special training in a 
surgical technique with limited excess for trainees to the small operative field. 
2. Radical abdominal trachelectomy is a technically feasible operation in adult and 
pediatric patients. ART has been developed and introduced in the every-days practice 
of gynecologic oncology throughout the world without demand of a special training. 
3. ART is a safe method in terms of oncological outcomes. Long term quality of life 
consequences are better compared to radical hysterectomy. Pregnancy rate: most 
women (74%) attempting pregnancy after ART are able to achieve pregnancy and 
most of them deliver in the third trimester (52%). 
4. VRT and ART seems to be oncologically safe method in patients with < 2 cm of 
tumor diameter. No clinical study has compared the two techniques so far. Less 
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radical treatment methods are under investigation. VRT is not recommended in 
cervical cancer treatment > 2 cm of tumor diameter. 
5. A well-defined extension of the radical hysterectomy with clear anatomic borders and 
extensive removal of the pelvic connective tissue compartments seems to be an 
advantageous alternative of traditional (less extensive surgery combined with adjuvant 
radiotherapy) treatment for most patients with stage IB cervical cancer. 
6. Oncological outcome of ART operated patients have been found identical to cases, 
treated by traditional methods. This technique seems to provide good oncological 
safety in cases, where the tumor diameter is above 2 cm. 
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1. Introduction 
 
1.1. Cervical cancer  
 
Cervical cancer is the second most common cancer in women in lower income, 
developing countries and the seventh most common cancer in countries with high GDP. More 
than 500 000 new invasive cervical cancer cases are estimated to be diagnosed worldwide 
every year.1 The precise number of diagnosed cancer cases and the age distribution are 
unknown, because not all countries have complete cancer registration. In developed countries 
with a good public health infrastructure, screening of cervical cancer has led to an impressive 
reduction in incidence and mortality.  
The major histologic types of invasive cervical carcinomas are squamosus cell 
carcinomas and adenocarcinomas. Squamosus cell carcinomas comprise 80% of cases, and 
adenocarcinoma and adenosquamous carcinoma comprise approximately 15 %. Even though 
the major histological type is squamous cell carcinoma, the ratio of adenocarcinomas 
increased to two folds in the past 20 years.  
The staging of cervical cancer regarding the FIGO staging system is based upon the 
clinical finding. The staging system for cervical cancer was initiated by FIGO 1979. The 
current form of the staging system was adopted by the FIGO in 2009 after many revisions has 
been widely utilized throughout the world ( Table 1.) .  
Most patients in higher income countries who are diagnosed in the early stages of the 
disease have a good chance for being cured. However, both traditional treatment alternatives 
in early stage diseases (radical surgery and radiotherapy) destroy the fertility, and 
consequently both methods can lead to psychosexual dysfunction and a decreased quality of 
life (infertility increases the frequency of depression, stress, and sexual dysfunction.2,3) The 
mean age of women planning pregnancy in higher income societies has increased. 
Postponement of childbearing coupled with the comparatively young age at which many 
women are diagnosed with cervical cancer. 4 It’s estimated that nearly 50% of all patients 
eligible for surgical management5 are younger than 40 years of age.  
Partial radical organ resection has become the optimum treatment of choice in many solid 
tumors, such as partial gastrectomy, nephrectomy, pneumonectomy, and colectomy to treat 
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malignancies affecting these organs.6,7 In gynecologic oncology surgery, partial organ 
resection are relatively new techniques utilized in women with early cervical cancer who wish 
to retain fertility8. 
 
 
Table 1. : FIGO stage of cervical carcinoma 2009. 
 
 
Stage I  
 
Carcinoma strictly confined to the cervix; extension to the uterine corpus should be 
disregarded. The diagnosis of both Stages IA1 and IA2 should be based on microscopic 
examination of removed tissue, preferably a cone, which must include the entire lesion.  
 
 IA: Invasive cancer identified only microscopically. Invasion is limited to measured 
stromal invasion with a maximum depth of 5 mm and no wider than 7 mm.  
   
  IA1: Measured invasion of the stroma no greater than 3 mm in depth      and no 
wider than 7 mm in diameter.  
  IA2: Measured invasion of stroma greater than 3 mm but no greater than 5 mm 
in depth and no wider than 7 mm in diameter.  
  
 IB: Clinical lesions confined to the cervix or preclinical lesions greater than Stage IA. 
All gross lesions even with superficial invasion are Stage IB cancers.  
   
  IB1: Clinical lesions no greater than 4 cm in size.  
  IB2: Clinical lesions greater than 4 cm in size.  
 
 
 
 
 
Stage II  
 
Carcinoma that extends beyond the cervix, but does not extend into the pelvic wall. The 
carcinoma involves the vagina, but not as far as the lower third.  
 
IIA: No obvious parametrial involvement. Involvement of up to the upper two-thirds 
of the vagina.  
 
 IIA1: Clinical lesions no greater than 4 cm in size.  
 IIA2: Clinical lesions greater than 4 cm in size 
 
IIB: Obvious parametrial involvement, but not into the pelvic sidewall.  
	   10	  
 
 
 
 
Stage III  
 
Carcinoma that has extended into the pelvic sidewall. On rectal examination, there is no 
cancer-free space between the tumour and the pelvic sidewall. The tumour involves the lower 
third of the vagina. All cases with hydronephrosis or a non-functioning kidney.  
 
 IIIA: No extension into the pelvic sidewall but involvement of the lower third of the 
vagina.  
 
IIIB: Extension into the pelvic sidewall or hydronephrosis or non-functioning kidney.  
 
 
 
 
Stage IV  
 
Carcinoma that has extended beyond the true pelvis or has clinically involved the mucosa of 
the bladder and/or rectum. 
 
IVA: Spread of the tumour into adjacent pelvic organs.  
 
IVB: Spread to distant organs. 
 
 
 
1.2. The classical surgical treatment of cervical cancer. 
 
The classical surgical management of early-stage cervical carcinoma requires the 
extirpation of the uterus and cervix, along with radical resection of the parametrial tissues and 
upper vagina, together with complete bilateral pelvic lymphadenectomy (if pelvic lymph 
nodes positive some authors advocate periaortic lymphadenectomy as well).  
It was Pare in the 16th century who first proposed the amputation of a cervical 
carcinoma as a treatment option. However, at this time surgery resulted a high mortality and 
even in the 19th century when Freund  proposed and performed radical surgery for the 
management of cervical cancer, mortality rates of the procedure was still unacceptably high. 9 
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The birth of the 20th century saw advances being made in surgical specialities with the 
introduction of safer anaesthetics, better antiseptics and later antibiotics. Surgeons such as 
Clark 10 in America and Wertheim 11 in Austria were pioneering the use of radical surgery 
with the aim of curing cervical cancer. Schauta 12 was treating cervical cancer with radical 
vaginal surgery and Okabayashi 13 has developed his radical hysterectomy technique in Japan. 
At the same time, radiotherapy was developed following the discovery of radium by the 
Curies and its therapeutic application by Abbe 14. Many, even Wertheim himself, thought that 
radiotherapy would replace surgery for the treatment of cervical cancer. However, in the mid 
20th century the radical hysterectomy and lymphadenectomy was reintroduced mainly 
through the work of Victor Bonney 15 in England and Joe Meigs 16 in America. In view of 
curative effectiveness and quality of life consequences radical surgery was demonstrated 
advantages over the radiotherapy, especially in young, early stage cohort of patients. 
This operation yields 5-year survival rates of 75%-95%, in most reported series. Although the 
surgical principles of this operation were first described more than one hundred years ago, it 
has undergone only minor modification throughout the years and remains the basis for the 
surgical approach utilized by gynecologic oncologists today. 17-19 
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1.3.Initial steps in preserving the fertility of cervical cancer patients. 
 
The idea of preserving the uterine corpus and the adnexae during radical hysterectomy 
was first published by Aburel in 1932 and cited by Chiricuta in a Romanian textbook.  This 
first conservative surgical approach was named ‘‘subfundic radical hysterectomy’’ by a 
Romanian gynecologist. No follow up data or successful pregnancies were reported .20 In 
1952 Novak presented a radical trachelectomy operation, which could be performed in 
women of reproductive age with cervical cancer in situ. Selected patients had to insist to be 
operated conservatively. He stated that this operation would be a radical extirpation of the 
cervix and upper part of the vagina, together the corresponding paracervical and paravaginal 
tissues .21  
The first successful systematic conservative surgical approach for invasive cervical 
carcinoma was described and published by Dargent in 1994. This operation was referred to as 
radical vaginal trachelectomy and included a laparoscopic pelvic lymphadenectomy, which 
was followed by the removal of the cervix together with surrounding parametria in order to 
protect the corpus of the uterus and the ovaries.22 
Concerns regarding the oncological safety of the method include the incomplete 
removal of the lateral parametria. Previous studies have demonstrated however, that 
parametrial metastases have a random pattern, thus partial resection of the parametria might 
hamper the oncological safety of the procedure. 23-24 By the use of the vaginal radical 
trachelectomy in larger tumours (>2 cm), recurrence rates as high as  29% have been reported. 
25   
Smith J.R. et Ungar L. in 1997, reported their technique (abdominal radical 
trachelectomy) with the aim to preserve fertility of early stage cervical cancer cases without 
the oncological risk of incomplete parametrectomy. Abdominal radical trachelectomy has the 
potential to overcome some of these problems as the radicality (parametria resection) of the 
procedure can be identical to that of a traditional type III Wertheim hysterectomy. In the new 
technique the uterine cervix, complete parametria, and vaginal cuff were excised. A complete 
lymphadenectomy has been part of the ART procedure. The remaining uterine corpus was 
harvested (sutured) to the vagina 26-27. 
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2. Fertility preservation techniques  
2.1.Vaginal Radical Trachelectomy ( VRT ) 
 
VRT consists of 2 main components; laparoscopic pelvic lymph node dissection and 
removal of the cervix up to the isthmus of the cervical canal, together with the surrounding 
parametrial and paracervical tissues via the vaginal route. This segment of the operation is 
similar to the Schauta’s radical vaginal hysterectomy. A circumferential incision is made in 
the upper vagina, the rim of the vaginal mucosa is delineated, and a vaginal cuff is formed. 
Anterior and posterior vaginal mucosa are sutured to prevent tumor cell spillage (or closed 
with strong Chrobak forceps). Anteriorly, the supracervical ligament is cut and the bladder 
base is mobilized. Posteriorly, the Douglas pouch is opened then laterally, both pararectal 
spaces are entered. This maneuver delineates the recto- vaginal ligaments (inferior parts of the 
utero sacral ligament) that are divided using bipolar scissors. Similarly, both vesicovaginal 
ligaments (also called bladder pilars) have to be defined. For the purpose both paravesical 
spaces are entered laterally. At this point, the ureter has to be found out by palpating the 
bladder pillar on the retractor in- stalled in the paravesical space. The knee of the ureter is 
identified by palpation, and then the bladder pillars are separated from the cervix. When 
clearly identified by palpation, bladder pilar underneath the knee of the ureter can be divided. 
The bladder base is therefore completely detached from the cervico-isthmic part of the uterus 
which is maintained only by the lateral part of the cardinal ligaments. The arch of uterine 
artery is identified. Then a right angle forceps is passed through the paraisthmic window just 
underneath the uterine artery arch to define the upper limit of each cardinal ligaments. 
Checking again the position of ureters, clamps are placed on the proximal part of the cardinal 
ligament straight below the ureters and they are divided. Other clamps are placed 
perpendicularly to enable the selective ligature of the cervico vaginal arteries. Next, the 
proximal parametrium is resected after the re- identification of the ureters. The cervicovaginal 
branches of the uterine artery are selectively ligated while carefully avoiding damage to the 
uterine artery. The cervix is then amputated below the cervical isthmus and a trachelectomy 
specimen should be sent for a frozen section examination to ensure that the surgical margins 
are tumor-free. Endocervical surgical margins should be tumor-free at least 5-8 mm from the 
level of the tumor, and a 2 cm tumor-free vaginal cuff must be achieved, otherwise more of 
the endocervix should be removed, or a RH should be considered. Ideally, surgical margins 
	   14	  
should be negative at least 1 cm beyond the tumor with 1 cm margins, including the 
paracervical tissues, and a vaginal cuff of at least 2 cm. If oncologically safe margins have to 
be obtained, a permanent cervico-isthmic cerclage is performed using a Prolene suture. 
Finally, the vaginal mucosa is reapproximate on closed to the new exocervix with interrupted 
sutures. 
28,29
 
Oncological outcomes, such survivor and recurrence datas are the most important 
factors of such a relatively new technic. The vaginal approach – more than 600 cases of 
cervical cancer managed by VRT have been described in the literature - appeared to be 
oncologically safe in well selected patients with early stage disease and lesion size less than 2 
cm based on the published articles. 30-34 Gien et al recently reviewed the literature on 600 
cases and report an overall recurrance rate of 5,3 % and death rate of 3,4 %. The published 
datas showed, that the procedure is oncologically safe, but the recurrance rate is increased in 
tumor size over 2 cm. 33  The recommended inclusion criteries are seen in Table 2. 
Pregnancies after VRT were published by different centers. 30,35-37 
The explanation of the high recurrence rate over 2 cm tumor size could be the that VRT 
cervical specimen correlates to a Class II radical abdominal hysterectomy as described by 
Piver, Rutledge and Smith.38 ( Figure 1., Photo 1. ) Incomplete removal of the lateral 
parametria where random metastases have been demonstrated histologically could be the 
reason of high failure rate in larger tumors.39,40 In addition, learning the vaginal radical 
procedure can be difficult due to the limited access to the operative field for teaching and the 
low number of suitable candidates in individual centers. 
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Table 2. 
1. Strong fertility desire 
2. Age <40 years  
3. Proven diagnosis of invasive cervical cancer; ideally, disease located primarily on the 
ectocervix 
4. Stage Ia1 with LVSI, Ia2, Ib1; Tumor size <2 cm 
 6. Limited endocervical involvement can be exactly determined by colposcopic examination 
and/or MRI; 
7. No evidence of pelvic lymph node metastasis and/or other distant metastasis 
8. Exclusion of unfavorable histology (e.g., neuroendocrine carcinoma) 
9. Gynecologic oncologist who has an experience in laparoscopic and radical vaginal surgery 
Figure 1.  
 
 
 
 
 
 
 
 
 
	  
VRT	  
Radical	  
Hysterectomy	  
Class	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Photo 1. 
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2.2.Abdominal Radical Hysterectomy ( ART ) 
 
As the first step of the ART procedure the peritoneum lateral and parallel to the 
infundibulopelvic ligament is opened, (round ligaments are preserved) and the pelvic 
retroperitoneal space is entered. A thorough pelvic lymphadenectomy, by removal of the 
complete fibro-fatty tissue content of the pelvic retroperitoneal space is completed from the 
levator any muscle level to the level of the bifurcation of the aorta is performed. The extent of 
the pelvic lymphadenectomy is identical to that in a traditional Piver type III radical 
hysterectomy, including the common iliac, superior gluteal, subaortic, presacral, external iliac 
and obturator nodes. The nodal tissue is analyzed by frozen pathological sections. If tumor is 
detected within the lymph nodes, the abdominal radical trachelectomy procedure is 
abandoned and the operation is converted to a laterally extended radical hysterectomy 
41,42 
and 
pelvic/ paraaortic lymphadenectomy or the patient is referred to chemo-radiotherapy. 
The uterine vessels are ligated at their origins and the uterine corpus transected at the 
level of the internal os of the cervical canal. A cross section of the superior portion of the 
separated cervix is sent for frozen section to ensure a tumor-free margin towards the uterine 
corpus. The infundibulo-pelvic vessels, (which provide uterine perfusion), are mobilized and 
the uterine corpus retracted on them for the remaining parts of the operation 
(parametrectomy). The cervix is removed together with the parametria and the upper brim of 
the vagina, as in a conventional radical hysterectomy. ( Figure 2., Photo 2. ) Following a 
thorough dissection and removal of the cervix, parametria and upper vagina, the proximal 
vaginal margin is resutured to the seromuscular margin of the retained uterine body with a 
single layer running suture to re-establish continuity.  
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Figure 2. 
 
 
Photo 2. 
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Abdominal radical trachelectomy has the potential to overcome some concerns in 
regard to the VRT procedure. The radicality of the procedure can be identical to that of a 
traditional type III Wertheim hysterectomy. ( Figure 3. , Photo 3. ) The surgical-technical 
similarity of the abdominal radical trachelectomy and the traditional Wertheim procedure 
makes this technique easily adopted by surgeons having experience in radical hysterectomy. 
The number of RH procedures in high income countries have decreased, and fertility sparing 
surgery is applicable only for a small selected cohort of this shrinking group of cases. 
Considering these points of view, ART technique that does not need a special training for 
trained Wertheim surgeons seems to have an important advantage over VRT 43-45. 
 
Figure 3.  
 
 
 
Our initial experience with the ART technique was published in 2005.43 The 33 
cervical cancer patients who expressed a desire for fertility-preserving surgery during the time 
period of 1997-2002 and underwent the procedure make up this prospective cohort, with 
follow up of all patients until October 2003. Three procedures were abandoned after positive 
pelvic nodes (two patients) and involvement of the margin between the amputated cervix and 
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the uterine fundus with tumor (one patient) were detected. The mean age of the remaining 30 
patients was 30.5 years (range 23–37), mean weight 64.3 kg (range 50 – 85 kg); mean length 
of operating time 3 hours 46 minutes (range 2 hours 50 minutes to 5 hours) and mean number 
of lymph nodes removed from the pelvis 32.2 (range 17 – 44). Ten patients had FIGO stage 
IA2 tumors ( 9 squamous and 1 adenosquamous carcinoma ), 15 had stage IB1 ( 14 squamous 
and 1 adenocarcinomas ), while 5 women had stage IB2 tumors (3 squamous and 2 glassy cell 
carcinoma). Four of the stage IB1 tumors were over 2 cm in diameter. The largest tumor was 
6 cm in diameter. One clinical stage IB1 tumor exhibited microscopic spread of tumor to the 
upper vagina. Lymphovascular space invasion was noted in 1 of 10 stage IA2, 3 of 15 stage 
IB1 and 4 of 5 stage IB2 tumors. Two of the tumors with lymphovascular space invasion also 
demonstrated perineural spread. Tumor-free margins of more than 5 mm were present in all 
cases. Patients with non-squamous tumors were advised of the risk of ovarian and distant 
metastases and all insisted on fertility-retaining surgery. No recurrences have been detected to 
date of publication, with a median follow up of 47 months (mean 32 months, range 14 – 75 
months). A normal menstrual pattern resumed within eight weeks of surgery in all but two 
patients. In these two women, ultrasound examination was suggestive of obliteration of the 
endometrial cavity. Five of the 30 patients have tried to conceive resulting in two spontaneous 
and one IVF pregnancies. One pregnancy ended in miscarriage at five weeks estimated 
gestational age. Two patients delivered healthy babies at term by caesarean section with no 
complications. The babies weights were 3200 and 3350 g despite the reliance on the ovarian 
vessels for uterine perfusion. 
Recently published datas of 3 institutions where patients planned for ART from 1999 
to 2011. 101 patients were planned to retain the fertility, 70 of 101 women who had neither 
hysterectomy nor adjuvant therapy, 38 (54%) attempted pregnancy and 28 (74%) achieved 
pregnancy. Thirty-one pregnancies resulted in 16 (52%) third trimester deliveries. Six patients 
are currently pregnant with outcomes pending. Preservation of the uterine vasculature is not 
necessary for fertility; obstetrical outcomes are similar to those of the historical vaginal 
radical trachelectomy cohorts. 96 
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Photo 3. 
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2.3.Radical Trachelectomy ( RT ) procedure with different technics  
2.3.1.Laparoscopic Radical Trachelectomy 
 
A laparoscopic alternative to the abdominal approach was developed for the use in 
centres where laparoscopic radical hysterectomy is a routine surgical treatment of early stage 
cervical cancer. The first laparoscopic abdominal radical trachelectomy was performed by 
Lee and colleagues. 46 Since that time, other investigators (including our team) have published 
their experience with this approach.47-50 
The technic is the following 47 : 
A 10-mm trocar was inserted supra-umbilically and two 5-mm trocars laterally to the 
umbilicus and lateral to the inferior epigastric vessels in each side. The surgery started with  
dissection of pelvic retroperitoneal space. Systematic pelvic lymphadenectomy followed to 
the level of aorta bifurcation. Lymphatic tissue was sent for intraoperative histology. 
Negativity of pelvic nodes was considered essential condition for continuation in procedure. 
Ascendant branches of uterine vessels were cut at the level of the internal os and uterine 
corpus was separated from the cervix. Mobile uterine corpus connected to blood supply by the 
infundibulopelvic ligament and the round ligaments only was easily moved aside the 
operation field. An upper 5 mm slice of the resected cervix was cut and sent to frozen section 
to prove clean margins. The cervix was manipulated by 10 mm sharp grasper and a standard 
radical procedure continued. Paravesical and pararectal spaces were developed to the level of 
levator muscle fascia using dissecting forceps, uterine arteries were coagulated and cut at the 
level of hypogastric artery, lateral parametria were carefully transsected at the pelvic side wall 
using haemoclips, harmonic scalpel and scissors. Rectovaginal space was entered and bluntly 
developed, bladder peritoneum was opened and bladder dissected from the upper part of 
vagina, and ureter was completely freed from parametria. Bladder was sharply dissected from 
lateral parametria exposing bladder pillars, which were coagulated and resected at the 
posterior wall of the bladder. Posterior parametria were coagulated and transected from the 
sacrum to the level of final vaginal resection margins. Vagina was packed with two surgical 
gloves to prevent gas leakage. Finally, vagina was circularly cut by unipolar hook and cervix 
with vaginal cuff removed vaginally. Seromuscular edge of resected uterine corpus was fixed 
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to proximal vaginal vault with continuous running suture. 
 
2.3.2. Robot-assisted laparoscopic fertility sparing Radical Trachelectomy 
 
The da Vinci system provides instruments with a wrist function at the tip, movement 
downgrading, tremor elimination, a stable 3-dimensional view and an ergonomic working 
position. These features may help the surgeon overcome some of the limitations associated 
with traditional laparoscopic surgery. The first robot-assisted trachelectomy was performed in 
2007.51 The technique is new and only 37 cases have been published in English literature to 
date. Reproducibility and accuracy have been studied and compared to the vaginal approach. 
It demonstrated that for robot-assisted trachelectomy the length of the remaining cervix was 
equally accurate as for the vaginal approach, the length of the parametria removed was 
longer.45 Standardized technic of the procedure is not written here, because only a few studies 
were published until now. 51-54 
 
 
2.4. Special indications for ART procedure 
 
2.4.1.Gestation and early cervical cancer 
 
The occurrence of malignancies during pregnancy has increased over the last decades. 
They complicate approximately 1 per 1000 pregnancies. There is almost always a conflict 
between optimal maternal therapy and fetal well-being, since either maternal or fetal health, 
or both, will be compromised. Treatment delay for the sake of the maturation of the fetus is 
the generally adopted policy in cases where cervical cancer is diagnosed during the 2nd half of 
the pregnancy. In cases of invasive cervical cancer diagnosed in the first trimester of a 
pregnancy, treatment delay - necessary to secure the health chances of the fetus - would 
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impose an undue maternal risk. Treatment of the mother without delay, that immolates the 
fetus, has become the general policy of treatment. Besides, the incidence of cervical cancer is 
increasing in young women at a time when they are delaying their childbearing. 
Abdominal trachelectomy has been reported by our team56 as a potential option in 
patients who have strong desire to attempt preservation of pregnancy, fertility and treat the 
cancer diagnosed in the first trimester of pregnancy without delay. Our first experience was 
followed in other institutions by advances in fertility-sparing surgery for stage IB1-2 cervical 
cancer lead to the successful utilization of radical abdominal trachelectomy during the early 
second trimester of pregnancy. This approach in early gestation is feasible and resulted in a 
favorable oncologic and obstetrical outcome. From technical standpoint it appears that 
unilateral uterine vasculature perfusion is sufficient in our successful cases reported to carry 
the pregnancy to term without evidence of fetal growth restriction. Unlike other treatments 
(radical hysterectomy, radio-chemotherapy) ART did not result pregnancy terminations.  
Radical trachelectomy may provide a unique option for first trimester pregnant women with 
stage IB1 and 2 cervical cancer who have a strong desire to avoid definitive pregnancy 
termination and commence treatment without delay.55-56 
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2.4.2. Pediatric ART for tumors arising in site of the cervix 
 
A 14-year-old girl who was discovered to have a large solitary fibrous tumor of the 
uterine cervix, an unusual site for these tumors, to highlight the diagnosis and management if 
these tumors. Complete resection was achieved by means of a fertility sparing ART.57 
Solitary fibrous tumor ( SFT )are rare mesenchymal tumors arising in the pleura, 
mediastinum, pericardium, lung parenchyma, parotid, abdominal and pelvic organs.58 
Complete resection with a clear surgical margin is usually a curative treatment for these 
tumors. Local recurrence or metastasis, usually to bone, lung or liver is thought occur in 10-
15 % of  SFTs but has been described in up to a third of tumors in reported series. Lymph 
node metastasis appears to be rare; in one large series, lymph node metastasis was reported in 
6 of 223 cases ( 3 % ).59 Due to the generally excellent clinical outcome with complete 
surgical resection there are no systematic trials of chemotherapy or radiotherapy in these 
patients.58,60  Two additional reports were published by the same group about embryonal 
rhabdomyomsarcoma and cervical clear cell carcinoma arising in the cervix.61,62 
 
 
3. Fertility preserving in different prognostic groups of patients 
3.1 Fertility preserving at patients with less than 2 cm of tumor diameter 
3.1.1. ART and VRT 
 
Tumor size is an important criterion for fertility preservation surgery in most centers. 
If tumor stage I/A/1 without LVSI a simple conisation is considered an oncological safe 
method treating cervical cancer. Most international protocols (NCCN, ACOG) consider 
appropriate candidates for fertility sparing surgery patients with tumors of FIGO stage IA1 
with lymphovascular space involvement (LVSI), IA2, and IB1. Most centers include stage 
IB1 tumors of less than 2 cm only. Oncology outcomes are reported acceptable if the tumor 
does not exceed 2 cm in diameter and if it does not infiltrate more than half of the cervical 
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stroma.29,32,63  The 5-year survival rate is around 95% in these series. With the same treatment 
strategies (limited extent pelvic connective tissue removal) in IB1 tumors larger than 2 cm, 
the risk of recurrence following limited radicality procedures is significantly higher.
25 Expert 
colposcopy, high quality imaging and EUA is the standard examination before decision is 
reached about the feasibility of fertility sparing surgery, and one important parameter is the 
exocervical diameter.
63,64,65,66  
Beside the size of the tumor and the stromal invasion  LVSI is the most commonly 
discussed risk factor.
67,68 LVSI was present in around a third of women who underwent 
fertility sparing surgery in a number of materials.69,48,38   Most centers consider these risk 
factors, and regard the combinations of the prognostic parameters as potential exclusion 
criteria.  
VRT and ART are generally considered oncologically safe under the limit of 2 cm 
tumor size. In more than 10% of reported cases, VRT was done in tumors larger than 2 cm. A 
comparison of recurrences in tumors less than 2 cm in size (12 recurrences in 409 women 
[2·9%]) with recurrences in tumors larger than 2 cm (11 recurrences in 53 women [20·8%-
28%]) shows that VRT is a risky procedure for tumors larger than 2 cm.29,32,38 
Characteristics, oncological outcome, and pregnancy outcome of  VRT and ART in Table 4 
and 5. 
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Table 4. 
 
Table 5. 
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3.1.2. Less radical technics 
 
Several studies have shown that <1% of patients with early cervical cancer with 
favorable pathologic characteristics have parametrial involvement. 71-74 In addition, it has been 
shown that in approximately 60% of patients undergoing radical trachelectomy, the final 
pathologic specimen contains no residual disease.29 Retrospective studies of parametrial 
involvement in small tumours with infiltration of less than 10 mm or less than half of the 
stroma, with negative pelvic lymph nodes, support less radical surgery without resection of 
paracervical tissue.71-74 The minimum risk of parametrial involvement in cases of negative 
SLNs was confirmed by the first prospective study.
75  
There are only a few case reports about conisation or simple trachelectomy with or 
without lymphadenectomy in cervical cancers. A less radical surgical protocol was first 
published by Rob and colleagues.63 This procedure is divided into two steps: first, 
laparoscopy, SLN identification and frozen section, and pelvic lymphadenectomy are done; 
second, conisation (stage IA1 with LVSI and stage IA2 tumors) or simple trachelectomy 
(stage IB1 tumors, less than 2 cm) are undertaken when the SLNs are negative. Updated 
findings were published in 2008.
70 Of the 40 patients enrolled, 6 (15%) had positive sentinel 
lymph nodes on frozen section, and radical hysterectomy with pelvic lymphadenectomy was 
immediately performed. In the remaining patients, only a pelvic lymphadenectomy was 
performed. Following a 7-day interval to allow pathologic confirmation of negative lymph 
nodes, a large cone or simple vaginal trachelectomy was performed. With a mean follow-up 
of 47 months, one recurrence has been reported in a patient with a stage IB1 tumor with 8 mm 
of cervical stromal invasion and LVSI present. The patient was treated with chemoradiation 
and was reported to be without evidence of disease 62 months post-treatment. 
Characteristics and oncological outcome of patients who underwent simple trachelectomy or 
large cone are seen in table 6. 
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Table 6. 
 
 
 
 
3.2.Fertility preserving at patients with more than 2 cm of tumor diameter 
3.2.1.Neoadjuvant chemotherapy 
 
One of the limitations of fertility preserving surgery is deep stromal invasion and 
tumors larger than 2 cm. VRT in tumors larger than 2 cm shows high recurrence rate, hence 
it’s a risky procedure in these special cohort of patients and not recommended to perform. 
Some centers use neoadjuvant chemotherapy in “bulky” cervical cancers with the aim of 
downstaging before radical hysterectomy. 76,77 Currently, three approaches have been 
published on neoadjuvant chemotherapy and fertility sparing surgery. First, Maneo and 
colleagues used neoadjuvant chemotherapy before fertility sparing surgery ( conisation ). 78 21 
women with tumors 10–30 mm in size  ( 12 patients > 2 cm of tumor diameter ) were 
included in this protocol. In 16 of these women, fertility was preserved. Minimum (less than 3 
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mm) or no residuum was found in 17 women, and none of the patients’ tumors progressed on 
chemotherapy. Initially, lymphadenectomies were done by laparotomy, and then 
laparoscopically. Two women had positive lymph nodes. No recurrences were noted, but 
three women had precancerous lesions during follow-up.  
Plante and colleagues reported on three women who had neoadjuvant chemotherapy. 
79 The protocol of chemotherapy was the same as in the study by Maneo and colleague and 
only tumors between 3 and 4 cm were included. Surgery consisted of laparoscopic pelvic 
lymphadenectomy, with identification of SLNs, and VRT. Complete histopathological 
remission was achieved in all cases. In August 2009, all the patients were without evidence of 
disease; one patient delivered one baby and one patient delivered two (table 7). 
The third approach is known as the Prague protocol.80  Women with tumors larger 
than 2 cm, but which had not infiltrated more than two thirds of the stroma, were included. 
High dose density neoadjuvant chemotherapy was used: three cycles of chemotherapy at an 
interval of ten days. Fertility was preserved ( simple trachelectomy ) in seven of nine women. 
One woman opted for a radical hysterectomy after chemotherapy. Positive endocervical 
margins were present in another patient. Complete remission or minimal residuum of less 
than 2 mm was diagnosed in seven patients (table 7). One recurrence in the ovary was 
diagnosed 6 weeks after spontaneous delivery. This woman died of haematogenous 
dissemination of the tumor. Five women became pregnant. 
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Table 7. Characteristics, oncological outcome, and pregnancy outcome after neoadjuvant 
chemotherapy and fertility sparing surgery 
 
 
 
In the latest report by Köhler et al 81 18 cervical cancer patients with stage IB1 ≥ 2 cm 
in diameter or stage IB-2 recruited wishing to preserve fertility were offered the opportunity 
to be treated with neoadjuvant chemotherapy if prior laparoscopic pelvic and paraaortic 
lymphadenectomy showed no metastasis. In 67% of these women tumor positive lymph nodes 
were detected and therefore they received chemoradiation therapy. After a mean follow-up of 
25.2 months nine patients are without disease and three recurred and deceased. Six women 
(33%) received NACT in a three weekly scheme, afterwards VRT was performed. No 
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relapses were observed in the group of women receiving NACT and RVT (follow up in this 
group 30.6 months [range: 8–70]). 
All the above-mentioned studies were different in terms of the surgical radicality used 
after neoadjuvant chemotherapy. The drawback of all studies in literatures is the small sample 
size and the relatively short follow-up. Neoadjuvant chemotherapy in fertility sparing surgery 
is an experimental concept, which requires verification in the future, especially concerning 
oncological findings.  
 
3.2.2. Radical hysterectomy in patients with tumor over 2 cm. 
 
Our goal was to find a surgical method to be used in patients with bulky tumors with 
an acceptable oncological outcome. It has been several times demonstrated, that the location 
of parametrial metastases in surgical specimens being randomly distributed with an equal 
number of metastatic foci in the lateral and medial parametria.39 Detailed analysis of pelvic 
relapse probability maps accomplished by Höckel et al 82 demonstrated that the most probable 
cause of the cervical cancer recurrence was incomplete removal of ligamentous mesometrium 
adjacent to the mesorectum, from the central lower to the peripheral upper parts. This is 
acceptable explanation for the failure of VRT procedure in tumors over 2 cm. Abdominal 
radical trachelectomy has the potential to overcome this problem as the radicality of the 
procedure can be identical to that of a traditional type III Wertheim hysterectomy. 
 
Nonrandomized retrospective studies demonstrated that adjuvant radiotherapy after 
radical hysterectomy decreased the risk of pelvic recurrence but did not improve the overall 
survival in high and intermediate-risk cervical cancer.83 Based on these data, we presumed 
that survival of surgically treated patients with cervical cancer might be improved by stringent 
complete removal of the parametria, which contains lymphatic nodes and vessels. 
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Our experience with surgically treated I/B/1-I/B/2 patients with cervical cancer 
 
In 1993, a well-defined extension of the radical hysterectomy with clear anatomic 
borders was stipulated and adopted by all gynecologic cancer surgeons at St. Stephen 
Hospital. Laterally extended parametrectomy (LEP) was adopted as standard treatment policy 
in cases of positive pelvic nodes proven by intraoperative histology.41  
Between November 1993 and November 2005, radical hysterectomy was performed in 
563 consecutive patients with stage IB cervical cancer at St. Stephen Hospital. We stipulated 
conditions indicative for adjuvant treatment as follows: disease spread beyond the anatomical 
borders of the excision (positive surgical margins and tumor spread to the ureter channel) or 
specific tumor spread direction (tumor breakthrough of the lymph node capsule, occult para-
aortic lymph node metastasis, and tumor spread to the uterine corpus). We consider these 
criteria to indicate poor prognosis, unlikely to be influenced by a more extensive 
parametrectomy.  
Clinical characteristics were collected from medical records. Overall survival data 
were obtained from the National Population registry and the National Health Care registry 
(every citizen of the Hungarian Republic is covered by the National Health Scheme, and 
oncological treatment is not possible outside NHS hospitals), which provide these data for 
every patient without anyone lost for follow-up. The living patients were followed up for 64 
to 145 months.  
 
Results 
The mean operating time of 563 completed radical hysterectomies was 190 minutes 
(range, 90-360 minutes); the mean blood loss was 800 mL (range, 50-4000 mL). Blood 
transfusion (average of 3 units) during or after surgery was needed in 70.0% of cases. No 
treatment-related death occurred. 
Forty-one patients (7.3%) had postoperative complications, which required surgical treatment. 
In 71 patients (12.6%), we advised adjuvant radiotherapy or chemoradiotherapy. No adjuvant 
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treatment was purposed in 492 (87.4%) of 563 completed radical hysterectomy cases. Clinical 
characteristics of the whole cohort of 563 patients are presented in Table 8. 
 
 
Table 8. 
 
According to our treatment protocol, 492 (87.4%) of the 563 patients did not receive 
any adjuvant treatment. The survival data are summarized in Table 9. Five-year overall 
survival of 492 patients with stage IB cervical cancer treated with radical hysterectomy 
without adjuvant therapy was 94.0%. Five-year overall survival in stage IB1 disease was 
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96.0%; in stage IB2, it was 87.0%. The number of dissected lymph nodes identified by 
pathologic examination ranged between 30 and 55.  Pathological stage, histologic 
classification, lymph node metastases, lymphovascular space involvement, and perineural 
spread did not seem to influence the prognosis.  Sixty-two patients (12.6%) had intermediate-
risk disease defined by GOG 92/RTOG 87-06 84 (presence of any 2 of 3 criteria: tumor size 
>4 cm, lymphovascular space involvement, and invasion >1/3 of the cervical stroma). Five-
year  overall survival in this group was 88.0%. One hundred twenty-eight patients (26.0%) in 
our  study had high-risk cervical cancer according to SWOG 8797/GOG 109/RTOG 911 
criteria. Seventy of them were lymph node positive; the 5-year overall survival of these 
patients was 91.0%. Laterally extended parametrectomy procedure was performed in all 
lymph node-positive cases. The 5-year overall survival of the patients with lymph node-
positive cervical cancer according to stage was as follows: stage IB1 (n = 26), 96.0%; stage 
IB2 (n = 16), 88.0%; pIIA (n = 12), 100.0%; and pIIB (n = 16), 81%. In 58 patients with 
lymph node-negative disease, the pathology stage was more advanced (stage pIIA or pIIB) 
than the International Federation of Gynecology and Obstetrics stage. The 5-year overall 
survival in this group was 88.0%. The 5-year overall survival of 190 patients (38.6%) at high 
and intermediate risk was 90.0%. 
Adjuvant chemoradiotherapy was advised in 71 cases (12.6%), in which final pathologic 
finding revealed tumor spread beyond the study criteria.  
94% overall survival was achieved with a completed 5-year follow-up as the result of 
a well-defined radical hysterectomy, which was used without adjuvant treatment in most of 
stage IB cervical cancer. This outcome is similar to the 96% 5-year overall survival after total 
mesometrial resection without adjuvant therapy reported by Höckel et al.82 It enabled us to 
assume that complete removal of the fibro-fatty tissue content of the pelvis provides at least 
the same or even better survival than any reported traditional treatment modality (Table 10).85-
87. Our aim was to define surgical borders of dissection irrespective of ligaments, lymph node 
groups, and surgical planes. In this respect, we neglected the anatomical definition of the 
removed tissue blocks and focused on structures left cleared from the overlying connective 
tissue. This surgical definition was possible to teach and learn; it was adoptable for all 
surgeons in our team. 
A well-defined extension of the radical hysterectomy with clear anatomic borders and 
extensive removal of the pelvic connective tissue compartments seems to be an advantageous 
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alternative of traditional (less extensive surgery combined with adjuvant radiotherapy) 
treatment of most patients with stage IB cervical cancer. 
 
 
 
Table 9. 
 
 
 
 
Table 10. 
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Conclusions of our study in relation to fertility preserving ART indications: 
 
1. Extensiv and well defined radical pelvic connective tissue removal (cellulectomy) 
provide equal or better survival chances than any combinations of surgery and or 
chemo-radiotherapy for  90% of Stage IB cervical cancer patients. 
2. Patients who are unfit for the surgery only treatment strategy (lymph node metastasis 
with tumor extending beyond the anatomy borders of the lymph node, paraaortic 
lymph node involvement, ureter channel involvement and tumor spread to the uterine 
corpus) are referrals for adjuvant treatment. 
3. Our selection criteria and results are identical to the results of other institutions, using 
similar surgical techniques.  
4. Since surgical technique, extent of the pelvic cellulectomy is identical between our 
radical hysterectomy and ART procedures, ART can be offered to patients who are fit 
for radical hysterectomy without adjuvant treatment. 
5. Based upon these considerations, ART in stage IB cervical cancer seems to be 
applicable, regardless of the size of the tumor.  
 
 
3.2.3. Our experience in use of Abdominal Radical Trachelectomy to treat Cervical 
Cancer greater than 2cm in diameter.  
 
Our surgical technique, with regards to the extent of clearance of the tumor cell 
containing pelvic connective tissue, is identical to traditional radical hysterectomy (RH), apart 
from the preservation of the uterine corpus and adnexae. RH as a curative intent treatment is 
recommended in Stage IB cervical cancer by ACOG and NCCN protocols.88 2cm size limit 
has never been mentioned as a contraindication for curative intent RH surgery. The RH 
experience has revealed an optimum curative outcome treatment with better or at least 
identical disease free  (DF) and overall survival (OS) to radiotherapy in larger than 2 cm 
tumors. 89 Our hypothesis was that oncology safety of patients diagnosed with tumors >2cm 
in diameter and treated by ART would be similar to cases managed by RH, in identical ICC 
prognosis groups. 
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Materials and methods 
Between January 1999 and October 2006, a total of 36 patients with cervical 
carcinoma FIGO stage IB1-IB2 measuring greater than 2cm in diameter were explored with 
the intent of a fertility sparing ART and pelvic lymphadenectomy. Exclusion criteria for the 
fertility preserving procedure were (i) tumours less than 2cm ; (ii) metastases reported 
following imaging; and (iii) follow-up lasting less than 5 years. ART was completed in 22 out 
of 36 patients (61,1%). Every patient was followed up for more than five years. No case was 
lost to follow up. 
 
Results: 
22 patients’ characteristics where ART was completed are listed in Table 11. Our 
clinical findings had to be supported by the imaging results. Lack of lymphadenopathy was a 
condition for ART. Patients who were found to have positive lymph nodes were excluded 
from the ART procedure, and were treated either with a laterally extended parametrectomy 
(LEP)  or with adjuvant chemoradiotherapy. 
14 out of 36 (38,9%) patients underwent immediate completion of radical 
hysterectomy based on the intra-operative findings including: positive lymph node metastasis 
(n=9), positive endocervical surgical margin (n=3), injury of the ovarian artery (n=1) and 
parametrial tumour spread (n=1). The following outcomes were recorded: average operative 
time - 194 minutes, estimated blood loss - 900 ml, in-hospital stay - 6 days, number of lymph 
nodes removed - 30-55. 
 
Mean 5-year overall survival of ART patients was 95%. Follow-up ranged from 60 
to148 months. 21 out of 22 (95%) patients who underwent ART were alive at the time of 
follow up. The  patient who died was first diagnosed with a stage IB2 glassy cell histology 
tumour measuring 5cm diameter. She developed a pelvic side wall recurrence five months 
after ART. She was subsequently treated with chemo-radiotherapy but did not respond. A 
pelvic exenteration was consequently performed but the patient died of disseminated disease 
16 months after the first treatment. 
In contrast 6 only out of 14 ( 42,8 % ) cases who did not match our criteria for ART surgery 
were alive at five years. 
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Table 11. 
 
Median age ( years ) 32,2 ( 24 -43 ) 
  
FIGO stage No. of patients (%) 
I/B/1 2 cm < tumor size < 4 cm 13 ( 59,9 % ) 
I/B/2 9 ( 40,1 % ) 
Hystology 
Squamous 11 ( 50 % ) 
Adenosquamous 4 ( 18 % ) 
Adenocarcinoma 1 ( 4,5 % ) 
Glassy cell 5 ( 23 % ) 
Anaplastic 1 ( 4,5 % ) 
Lymph Vascular space involvement 
( LVSI ) 
11 ( 50 % ) 
Treatment Characteristics 
Median OR time ( minutes ) 194 ( 150-240 ) 
Hospital stay ( days ) 6 (5-10 ) 
Median follow-up ( months ) 90 ( 60-148 ) 
Survival 
5 year overall survival 95% (21/22) 
5 year disease free survival 95% (21/22) 
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Complications post-ART 
 
One patient (n=1; 4,5%) was diagnosed with intraoperative one-sided ureteric injury 
necessitating a reconstructive ureter neo-implantation with a psoas hitch procedure. Late 
complications included cervical stenosis (n=1; 4,5%), where the patient underwent dilatation 
of her neo-cervix twice before her normal menstrual pattern recovered. Stenosis of both 
ureters developed in the follow-up period in one patient (n=1; 4,5%), which was repaired by 
excision of the affected sequence of ureters, and reconstructed by the use of a small bowel 
conduit connecting the ureters and the urinary bladder. 
 
Transient urinary retention necessitating a need for suprapubic or self-catheter use 
lasting longer than eight days was observed in five cases (22,7%). Bladder function 
spontaneously recovered in all cases within the first post-operative month. Constipation 
requiring regular laxative use to enhance defecation lasting longer than the first four weeks of 
follow-up were reported by four patients (18,1%). No lymphoedema was seen in this cohort 
of patients. 
 
Fertility outcomes 
 
Out of the 22 patients, eight wished to fall pregnant. One out of the eight underwent 
infertility treatment. Four pregnancies were recorded in three other patients. One pregnancy 
resulted in a first trimester miscarriage. Three pregnancies led to delivery of a healthy 
neonate, one at 28 weeks gestation and two at term. We must also emphasise that our follow-
up in view of pregnancy rate is not complete as we could not personally contact five patients. 
Theoretically there may be pregnancies that we do not know about. The rest of the cohort did 
not fall to pregnant at the time of writing or had recently changed partners. 
 
 
Discussion 
 
The operative standard therapy for women with IB cervical cancer is still RH which 
was developed more than 100 years ago. The postponement of childbearing coupled with a 
comparatively young age at which many women are diagnosed with cervical cancer has led to 
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the innovation of various fertility sparing procedures.4 Assuming the tumour does not exceed 
2cm in diameter at its largest point, oncology outcomes are very promising with respect to 
such procedures. In tumours surpassing the 2cm threshold, the reported use of such 
procedures is very limited. Furthermore, VRT cannot be proposed as a treatment option for 
large-size tumours because of its high recurrence rate.22,25,29,31 
In our study 36 patients diagnosed with Stage I cervical cancer measuring >2cm in 
diameter were surgically explored with the aim of ultimately undergoing ART. Patients that 
underwent ART were subsequently followed up for at least five years. The ART selection 
criteria applied in our series (negative surgical margins; negative lymph nodes in stage IB 
cervical cancer) was met by 61,1% (n=22) of our cervical cancer cases measuring >2cm in 
diameter. The five year survival rates for this case series (95%) are at least equal to rates 
reported in the literature for patients treated by radical hysterectomy +/- adjuvant therapy as 
the initial treatment.93 Our survival data seems to support our hypothesis that oncological 
safety of ART for lesions >2cm is identical to traditional cervical cancer treatment modalities 
for Stage IB cervical cancer. Furthermore, the goal of performing ART as opposed to RH has 
been realised in four patients who have to date delivered three healthy live babies.  
The relative large proportion of lymph node positivity (25%; 9/36), tumor spread to 
the uterine corpus (8,3%; 3/36) and occult stage IIB (2.7%; 1/36) might reflect the relative 
aggressive nature of cervical cancer in this very young age group.93 
In two recent reports regarding the ART procedure, the tumour size was both <2cm 
and >2cm. 38% of patients (n=5) with tumour diameter >2cm had recurrent disease during a 
follow-up period lasting 27 months (median).94 On the other hand Li et al reported that out of 
14 cases who underwent ART with exophytic tumour size between 2-4cm, no evidence of 
recurrent disease during a follow-up period of 22.8 months was recorded.95 Three patients 
received chemotherapy based on pathological findings.95 Such significant survival differences 
might be the consequence of small sample sizes, short follow-up, variances in surgical 
radicality and the accuracy of intra-operative selection of high risk cases. Future prospective 
randomised trials might further explore the questions listed above. The recurrence rate of 
tumours >2cm has also decreased in the literature as the surgical experience of ART has 
increased.93 
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4. Conclusion 
 
The aim of our study was to assess the oncologic safety of ART in large tumor 
patients (>2cm), compared to traditional RH or other possible first-line treatment options. Our 
data suggests that treatment guidelines for fertility preservation techniques have to distinguish 
between VRT and ART when it comes to treating relatively large (>2cm diameter) cervical 
cancers. VRT has been used in many centers with an excellent outcome and it may be 
preferred by surgeons in case of low risk tumors, such as those measuring <2cm in diameter. 
22,25,29-32 However the oncology, fertility, complication risk, quality of life consequences 
comparison of the two radical trachelectomy techniques in less than 2 cm tumors needs to be 
compared in prospective trials. The appropriate treatment of tumors > 2cm is with respect to 
both survival and fertility outcomes remains an enigma. The extent of parametrectomy in 
VRT is less extensive than in Type III radical hysterectomy.38 This might explain the lower 
survival witnessed following the application of VRT to treat >2cm diameter cervical 
cancers.30,31 Some centers use neoadjuvant chemotherapy in “bulky” cervical cancers with the 
aim of downstaging before radical hysterectomy. 76,77 Currently, four approaches have been 
published on neoadjuvant chemotherapy and fertility sparing surgery. All the published 
studies were different in terms of the surgical radicality used after neoadjuvant chemotherapy. 
The drawback of all studies in literatures is the small sample size and the relatively short 
follow-up. Neoadjuvant chemotherapy in fertility sparing surgery is an experimental concept, 
which requires verification in the future, especially concerning oncological findings. 78-81 
 
Results with a completed five-year follow-up of a relatively large cohort of patients 
have not been published to date. Our series seem to provide more extended experience in this 
field. Although still preliminary, our results are encouraging and indicate that even tumors 
>4cm may be successfully treated with ART. We recognize that a small case series of 22 
patients (such as ours) will not answer all questions regarding early-stage cervical cancer 
treatment. However ART applied to treat tumors >2cm appears to be safe. Future studies 
where ART is compared to RH with regards to management of cervical tumors >2cm might 
further clarify both survival and fertility outcomes. 
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